About Imperva (NASDAQ:IMPV)
Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company's products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.
Industry, Sector and Symbol
Industry Prepackaged software
SectorComputer and Technology
Trailing P/E Ratio-172.68
Forward P/E Ratio1,645.00
Sales & Book Value
Annual Sales$321.72 million
Price / Sales5.34
Cash Flow$0.0583 per share
Price / Cash845.88
Book Value$9.26 per share
Price / Book5.33
EPS (Most Recent Fiscal Year)($0.28)
Net Income$22.86 million
Return on Equity-3.28%
Return on Assets-1.94%
Imperva (NASDAQ:IMPV) Frequently Asked Questions
What is Imperva's stock symbol?
Imperva trades on the NASDAQ under the ticker symbol "IMPV."
How were Imperva's earnings last quarter?
Imperva Inc (NASDAQ:IMPV) posted its quarterly earnings data on Thursday, February, 8th. The software maker reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.13. The software maker earned $91.10 million during the quarter, compared to analysts' expectations of $91.11 million. Imperva had a negative return on equity of 3.28% and a net margin of 7.11%. The firm's quarterly revenue was up 16.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 EPS. View Imperva's Earnings History.
When is Imperva's next earnings date?
What price target have analysts set for IMPV?
16 brokers have issued twelve-month target prices for Imperva's shares. Their predictions range from $39.00 to $61.00. On average, they expect Imperva's stock price to reach $53.2308 in the next twelve months. View Analyst Ratings for Imperva.
What are Wall Street analysts saying about Imperva stock?
Here are some recent quotes from research analysts about Imperva stock:
- 1. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (4/11/2018)
- 2. Evercore ISI analysts commented, "We believe that the quarter was in part helped by the deposition of Skyfence which carried annual operating expenses of ~$25M (and revenue of ~$1M). There is likely a tailwind to margins in 2Q from the deposition as well, despite the company’s ongoing plans to reinvest the savings in growth areas. Management guided to ~7% non-GAAP margins for F17 which compares favorably to consensus of ~5.6% going into the quarter. We continue to believe that the company is working to improve its business but has largely overcome the execution challenges that plagued results last year. We are encouraged by the high level of growth (+64.5% y/y in 1Q17) seen in the company’s subscription offerings which may be further helped by the introduction of FlexProtect which makes form factor (on-prem vs cloud) less relevant. This should offset concerns on the company’s on-premise WAF decline." (5/5/2017)
Are investors shorting Imperva?
Imperva saw a increase in short interest in the month of March. As of March 15th, there was short interest totalling 1,847,957 shares, an increase of 56.0% from the February 28th total of 1,184,332 shares. Based on an average trading volume of 540,724 shares, the days-to-cover ratio is presently 3.4 days. Currently, 5.4% of the shares of the stock are sold short.
Who are some of Imperva's key competitors?
Some companies that are related to Imperva include Qualys (QLYS), Commvault (CVLT), Ellie Mae (ELLI), Paylocity (PCTY), BOX (BOX), ACI Worldwide (ACIW), Manhattan Associates (MANH), Coupa (COUP), Cornerstone OnDemand (CSOD), Descartes Systems Group (DSGX), Alteryx (AYX), BlackLine (BL), Mimecast (MIME), Cogent Communications (CCOI), Sailpoint Technologies (SAIL), Q2 (QTWO), Cloudera (CLDR) and Alarm.com (ALRM).
Who are Imperva's key executives?
Imperva's management team includes the folowing people:
- Allan Roger Tessler, Chairman of the Board (Age 81)
- Christopher S. Hylen, President, Chief Executive Officer, Director (Age 56)
- Mike Burns, Chief Financial Officer (Age 51)
- Tram T. Phi, Senior Vice President, General Counsel, Corporate Secretary (Age 46)
- Brett Hooper, Senior Vice President - People (Age 53)
- Sunil D. Nagdev, Senior Vice President and General Manager, Incapsula, Professional and Customer Services (Age 53)
- Terry Ray, Chief Technology Officer
- David Nicholas Gee, Chief Marketing Officer (Age 48)
- Amichai Shulman, Chief Scientific Officer (Age 47)
- Geraldine T. Elliott, Independent Director
Has Imperva been receiving favorable news coverage?
Media stories about IMPV stock have been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imperva earned a daily sentiment score of 0.07 on Accern's scale. They also gave news coverage about the software maker an impact score of 45.82 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Imperva?
Shares of IMPV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Imperva's stock price today?
One share of IMPV stock can currently be purchased for approximately $49.35.
How big of a company is Imperva?
Imperva has a market capitalization of $1.65 billion and generates $321.72 million in revenue each year. The software maker earns $22.86 million in net income (profit) each year or ($0.28) on an earnings per share basis. Imperva employs 1,020 workers across the globe.
How can I contact Imperva?
Imperva's mailing address is 3400 BRIDGE PARKWAY SUITE 200, REDWOOD SHORES CA, 94065. The software maker can be reached via phone at 650-345-9000 or via email at [email protected]
MarketBeat Community Rating for Imperva (IMPV)MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe IMPV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMPV will underperform the S&P 500 over the long term. You may vote once every thirty days.
Imperva (NASDAQ:IMPV) Price Target and Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
16 Wall Street analysts have issued ratings and price targets for Imperva in the last 12 months. Their average twelve-month price target is $53.2308, suggesting that the stock has a possible upside of 7.86%. The high price target for IMPV is $61.00 and the low price target for IMPV is $39.00. There are currently 2 sell ratings, 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Hold||Buy|
|Consensus Rating Score: ||2.50||2.50||2.41||2.58|
|Ratings Breakdown: ||2 Sell Rating(s)|
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
8 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$53.2308||$53.1538||$52.00||$50.90|
|Price Target Upside: ||7.86% upside||14.19% upside||24.25% upside||21.62% upside|
Imperva (NASDAQ:IMPV) Consensus Price Target History
Imperva (NASDAQ:IMPV) Analyst Ratings History
(Data available from 4/19/2016 forward)
Imperva (NASDAQ:IMPV) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Imperva (NASDAQ IMPV) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.10%
Imperva (NASDAQ IMPV) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/20/2018||Anthony J Bettencourt||Director||Sell||66,037||$46.98||$3,102,418.26||66,037|| |
|2/20/2018||Michael D Mooney||CRO||Sell||24,454||$47.18||$1,153,739.72||24,454|| |
|8/24/2017||Anthony J Bettencourt||Director||Sell||99,598||$43.59||$4,341,476.82||99,598|| |
|5/16/2017||Sunil D Nagdev||SVP||Sell||4,857||$49.00||$237,993.00||16,290|| |
|5/15/2017||Amichai Shulman||Insider||Sell||3,089||$48.70||$150,434.30||100,151|| |
|5/10/2017||Michael D Mooney||CRO||Sell||52,356||$47.51||$2,487,433.56||52,356|| |
|4/17/2017||Amichai Shulman||Insider||Sell||3,085||$41.97||$129,477.45||99,151|| |
|3/15/2017||Amichai Shulman||Insider||Sell||3,085||$41.85||$129,107.25||99,151|| |
|2/28/2017||Mark E Kraynak||SVP||Sell||45,314||$41.63||$1,886,421.82||10,064|| |
|2/21/2017||Anthony J Bettencourt||Chairman||Sell||84,863||$45.55||$3,865,509.65||84,863|| |
|2/21/2017||Terrence J Schmid||CFO||Sell||4,500||$45.53||$204,885.00||432|| |
|2/16/2017||Mark E Kraynak||SVP||Sell||1,731||$46.10||$79,799.10||3,858|| |
|2/15/2017||Amichai Shulman||Insider||Sell||3,085||$45.91||$141,632.35||95,713|| |
|1/17/2017||Amichai Shulman||CTO||Sell||3,085||$40.60||$125,251.00|| |
|12/21/2016||Amichai Shulman||Insider||Sell||3,085||$40.00||$123,400.00||91,830|| |
|11/16/2016||Mark E Kraynak||SVP||Sell||3,332||$40.16||$133,813.12||448|| |
|11/15/2016||Amichai Shulman||Insider||Sell||3,085||$40.10||$123,708.50||92,000|| |
|10/17/2016||Amichai Shulman||Insider||Sell||3,085||$48.57||$149,838.45||91,062|| |
|10/3/2016||Amichai Shulman||Insider||Sell||938||$53.27||$49,967.26||95,085|| |
|9/23/2016||Amichai Shulman||Insider||Sell||937||$51.00||$47,787.00||95,084|| |
|9/23/2016||Mark E. Kraynak||SVP||Sell||5,582||$51.00||$284,682.00|| |
|9/15/2016||Amichai Shulman||Insider||Sell||3,085||$44.30||$136,665.50||94,147|| |
|8/16/2016||Mark E Kraynak||SVP||Sell||2,614||$47.73||$124,766.22||3,552|| |
|8/15/2016||Amichai Shulman||Insider||Sell||3,085||$46.87||$144,593.95||94,317|| |
|7/27/2016||Amichai Shulman||Insider||Sell||3,085||$46.28||$142,773.80||93,380|| |
|7/26/2016||Mark E Kraynak||SVP||Sell||2,967||$46.15||$136,927.05||2,968|| |
|6/23/2016||Shlomo Kramer||Major Shareholder||Sell||75,000||$45.12||$3,384,000.00||1,304,521|| |
|6/20/2016||Shlomo Kramer||Major Shareholder||Sell||75,000||$40.24||$3,018,000.00||1,304,521|| |
|5/31/2016||Terrence J Schmid||CFO||Sell||5,000||$37.66||$188,300.00||335|| |
|5/25/2016||Anthony J Bettencourt||CEO||Sell||50,000||$36.15||$1,807,500.00||52,938|| |
|5/19/2016||Shlomo Kramer||Major Shareholder||Sell||50,000||$34.20||$1,710,000.00||1,304,521|| |
|5/17/2016||Shlomo Kramer||Major Shareholder||Sell||75,000||$33.95||$2,546,250.00||1,304,521|| |
|5/16/2016||Terrence J Schmid||CFO||Sell||7,000||$33.99||$237,930.00||8,053|| |
|5/12/2016||Shlomo Kramer||Major Shareholder||Sell||75,000||$34.16||$2,562,000.00||1,304,521|| |
|3/31/2016||Mark E. Kraynak||SVP||Sell||2,758||$50.00||$137,900.00|| |
|3/1/2016||Amichai Shulman||CTO||Sell||3,000||$45.25||$135,750.00||89,527|| |
|2/24/2016||Terrence J Schmid||CFO||Sell||6,500||$41.82||$271,830.00||7,468|| |
|2/17/2016||Mark E Kraynak||SVP||Sell||2,758||$40.04||$110,430.32||2,758|| |
|2/8/2016||Albert A Pimentel||Director||Buy||5,000||$38.93||$194,650.00||4,475|| |
|2/8/2016||Amichai Shulman||CTO||Sell||4,150||$38.12||$158,198.00||82,590|| |
|2/1/2016||Amichai Shulman||CTO||Sell||3,000||$50.49||$151,470.00||86,740|| |
|1/4/2016||Amichai Shulman||CTO||Sell||5,812||$60.36||$350,812.32||86,740|| |
|12/1/2015||Amichai Shulman||CTO||Sell||3,000||$74.22||$222,660.00||86,740|| |
|11/19/2015||Mark E. Kraynak||insider||Sell||10,000||$75.00||$750,000.00|| |
|11/19/2015||Tram T. Phi||VP||Sell||1,244||$73.26||$91,135.44||5,975|| |
|11/16/2015||Anthony J. Bettencourt||CEO||Sell||50,000||$69.33||$3,466,500.00||8,489|| |
|11/16/2015||Mark E. Kraynak||insider||Sell||3,789||$68.73||$260,417.97|| |
|11/12/2015||Shlomo Kramer||Major Shareholder||Sell||100,000||$71.65||$7,165,000.00||1,259,521|| |
|11/6/2015||Shlomo Kramer||Major Shareholder||Sell||50,000||$72.14||$3,607,000.00||1,259,521|| |
|11/4/2015||Shlomo Kramer||Major Shareholder||Sell||25,000||$72.05||$1,801,250.00||1,259,521|| |
|11/4/2015||Terrence J. Schmid||CFO||Sell||938||$71.14||$66,729.32|| |
|11/3/2015||Shlomo Kramer||Major Shareholder||Sell||25,000||$72.55||$1,813,750.00||1,259,521|| |
|10/1/2015||Amichai Shulman||CTO||Sell||2,813||$65.00||$182,845.00||84,802|| |
|8/31/2015||Terrence J. Schmid||CFO||Sell||1,595||$61.56||$98,188.20|| |
|8/17/2015||Mark E Kraynak||Insider||Sell||1,520||$71.42||$108,558.40|| |
|7/23/2015||Amichai Shulman||CTO||Sell||9,000||$70.00||$630,000.00|| |
|5/11/2015||Amichai Shulman||CTO||Sell||10,313||$51.09||$526,891.17|| |
|5/11/2015||Mark E Kraynak||Insider||Sell||4,000||$55.00||$220,000.00|| |
|4/20/2015||Mark E Kraynak||Insider||Sell||3,000||$47.53||$142,590.00|| |
|1/20/2015||Mark E Kraynak||Insider||Sell||3,000||$44.60||$133,800.00|| |
|1/8/2015||Amichai Shulman||CTO||Sell||1,875||$50.00||$93,750.00|| |
|12/16/2014||Amichai Shulman||CTO||Sell||9,492||$50.00||$474,600.00|| |
|12/15/2014||Amichai Shulman||CTO||Sell||11,133||$50.00||$556,650.00|| |
|12/1/2014||Amichai Shulman||CTO||Sell||5,000||$42.44||$212,200.00|| |
|11/28/2014||Yaniv Shaya||VP||Sell||2,512||$44.00||$110,528.00|| |
|11/20/2014||Mark E Kraynak||Insider||Sell||6,140||$42.00||$257,880.00|| |
|11/14/2014||Yaniv Shaya||VP||Sell||20,938||$44.52||$932,159.76|| |
|11/13/2014||Mark E Kraynak||Insider||Sell||2,000||$45.00||$90,000.00|| |
|11/11/2014||Tram T Phi||VP||Sell||10,076||$43.50||$438,306.00|| |
|11/4/2014||Terrence J Schmid||CFO||Sell||20,000||$40.73||$814,600.00|| |
|11/3/2014||Amichai Shulman||CTO||Sell||5,000||$41.09||$205,450.00|| |
|10/31/2014||Amichai Shulman||CTO||Sell||7,500||$36.56||$274,200.00|| |
|10/31/2014||Mark E Kraynak||Insider||Sell||2,000||$36.56||$73,120.00|| |
|10/6/2014||Amichai Shulman||CTO||Sell||2,500||$30.00||$75,000.00|| |
|9/2/2014||Amichai Shulman||CTO||Sell||5,000||$30.00||$150,000.00|| |
|8/21/2014||Terrence J Schmid||CFO||Sell||15,000||$29.07||$436,050.00|| |
|5/23/2014||Ralph Pisani||VP||Sell||8,613||$21.31||$183,543.03|| |
|5/21/2014||Terrence Schmid||CFO||Sell||15,000||$21.26||$318,900.00||2,853|| |
|4/7/2014||Shlomo Kramer||CEO||Sell||60,000||$50.53||$3,031,800.00||1,229,521|| |
|4/2/2014||Shlomo Kramer||CEO||Sell||40,000||$55.67||$2,226,800.00||1,229,521|| |
|1/8/2014||Shlomo Kramer||CEO||Sell||20,000||$50.10||$1,002,000.00||1,219,521|| |
|1/7/2014||Shlomo Kramer||CEO||Sell||40,000||$49.99||$1,999,600.00||1,219,521|| |
|1/3/2014||Shlomo Kramer||CEO||Sell||40,000||$48.31||$1,932,400.00||1,219,521|| |
|1/2/2014||Amichai Shulman||CTO||Sell||22,875||$47.68||$1,090,680.00||10,000|| |
|12/17/2013||Amichai Shulman||CTO||Sell||10,090||$45.00||$454,050.00||10,000|| |
|12/2/2013||Amichai Shulman||CTO||Sell||12,410||$44.13||$547,653.30||10,000|| |
|11/26/2013||Yaniv Shaya||VP||Sell||5,243||$43.92||$230,272.56||5,000|| |
|11/21/2013||Jason Forget||SVP||Sell||8,558||$38.98||$333,590.84|| |
|11/21/2013||Terrence Schmid||CFO||Sell||11,100||$40.26||$446,886.00|| |
|11/21/2013||Tram Phi||VP||Sell||6,646||$39.50||$262,517.00|| |
|11/19/2013||Mark Kraynak||VP||Sell||3,190||$37.80||$120,582.00||15,000|| |
|8/29/2013||Yaniv Shaya||VP||Sell||4,375||$48.00||$210,000.00|| |
|8/26/2013||Jason Forget||SVP||Sell||2,500||$47.50||$118,750.00|| |
|8/26/2013||Yaniv Shaya||VP||Sell||5,000||$47.71||$238,550.00|| |
|8/23/2013||Terrence Schmid||CFO||Sell||2,539||$47.20||$119,840.80|| |
|8/21/2013||Jason Forget||SVP||Sell||2,500||$47.00||$117,500.00|| |
|8/20/2013||Terrence Schmid||CFO||Sell||10,461||$47.03||$491,980.83|| |
|8/16/2013||Jason Forget||SVP||Sell||2,062||$47.00||$96,914.00|| |
|8/14/2013||Tram Phi||VP||Sell||5,000||$46.00||$230,000.00|| |
|8/13/2013||Jason Forget||SVP||Sell||2,000||$45.01||$90,020.00|| |
|8/13/2013||Mark Kraynak||VP||Sell||10,000||$44.41||$444,100.00||15,000|| |
|8/5/2013||Amichai Shulman||CTO||Sell||1,086||$52.58||$57,101.88|| |
|8/2/2013||Amichai Shulman||CTO||Sell||46,140||$51.87||$2,393,281.80|| |
|7/3/2013||Amichai Shulman||CTO||Sell||3,222||$45.21||$145,666.62|| |
|7/1/2013||Amichai Shulman||CTO||Sell||16,778||$44.94||$754,003.32|| |
|6/3/2013||Amichai Shulman||CTO||Sell||20,000||$39.49||$789,800.00|| |
|5/30/2013||Amichai Shulman||CTO||Sell||10,000||$39.93||$399,300.00|| |
|5/30/2013||Yaniv Shaya||VP||Sell||4,375||$40.40||$176,750.00|| |
|5/29/2013||Amichai Shulman||CTO||Sell||20,000||$39.96||$799,200.00|| |
|5/28/2013||Tram T Phi||VP||Sell||5,000||$40.25||$201,250.00|| |
|5/24/2013||Yaniv Shaya||VP||Sell||2,250||$40.00||$90,000.00|| |
|5/14/2013||Yaniv Shaya||VP||Sell||10,000||$39.00||$390,000.00|| |
|5/13/2013||Albert A Pimentel||Director||Sell||10,000||$37.93||$379,300.00|| |
|5/13/2013||Ralph Pisani||VP||Sell||5,000||$38.46||$192,300.00|| |
|5/13/2013||Terrence J Schmid||CFO||Sell||13,000||$37.75||$490,750.00|| |
|5/8/2013||Jason Forget||SVP||Sell||4,063||$37.31||$151,590.53|| |
|3/26/2013||Amichai Shulman||CTO||Sell||20,000||$38.30||$766,000.00|| |
|2/26/2013||Amichai Shulman||CTO||Sell||20,000||$36.05||$721,000.00|| |
|12/28/2012||Amichai Shulman||CTO||Sell||10,000||$31.01||$310,100.00|| |
|12/27/2012||Amichai Shulman||CTO||Sell||20,000||$30.98||$619,600.00|| |
|12/5/2012||Michael Boodaei||Director||Sell||30,000||$31.48||$944,400.00|| |
|11/27/2012||Amichai Shulman||CTO||Sell||20,000||$29.06||$581,200.00|| |
|11/7/2012||James R Tolonen||Director||Buy||5,000||$31.17||$155,850.00|| |
|11/1/2012||Amichai Shulman||CTO||Sell||20,000||$31.71||$634,200.00|| |
|10/4/2012||Michael Boodaei||Director||Sell||30,000||$34.03||$1,020,900.00|| |
|9/5/2012||Michael Boodaei||Director||Sell||20,000||$30.35||$607,000.00|| |
Imperva (NASDAQ IMPV) News Headlines
Imperva (NASDAQ:IMPV) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Imperva (NASDAQ:IMPV) Income Statement, Balance Sheet and Cash Flow Statement
Imperva (NASDAQ IMPV) Stock Chart for Thursday, April, 19, 2018